Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Risk Factors for Mild, Moderate, and Severe Alcohol Use Disorder (AUD) in a sample of adult substance users: Implications for DSM-5 AUD Classification

Zachary L. Mannes, Dvora Shmulewitz, Ofir Livne, Malka Stohl, Deborah Hasin
doi: https://doi.org/10.1101/2020.10.26.20219824
Zachary L. Mannes
aDepartment of Epidemiology, Columbia University Mailman School of Public Health, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dvora Shmulewitz
bNew York State Psychiatric Institute, New York, NY
cDepartment of Psychiatry, Columbia University Medical Center, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ofir Livne
aDepartment of Epidemiology, Columbia University Mailman School of Public Health, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Malka Stohl
bNew York State Psychiatric Institute, New York, NY
cDepartment of Psychiatry, Columbia University Medical Center, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deborah Hasin
aDepartment of Epidemiology, Columbia University Mailman School of Public Health, New York, NY
bNew York State Psychiatric Institute, New York, NY
cDepartment of Psychiatry, Columbia University Medical Center, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: deborah.hasin@gmail.com dsh2@columbia.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Though risk factors of Alcohol Use Disorder (AUD) have been well-studied, information is lacking on whether clinical characteristics differentiate between the three levels of severity (mild, moderate, severe) that were established for the first time in the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5). Therefore, in this study, we examined the association between alcohol consumption, mental and physical health, and functional impairment with the three DSM-5 AUD severity levels among adults age 18+ (N=588) pre-screened for problems with at least one substance. Participants recruited between 2016-2019 completed measures of AUD, harmful alcohol use, psychiatric conditions, and mental, physical, and social functional impairment. For each predictor, a multinomial logistic regression model was used to evaluate the association with a four-level AUD outcome (mild, moderate, severe, vs none), controlling for sociodemographic characteristics and other substance use. Twelve-month prevalence of none, mild, moderate, and severe DSM-5 AUD was 34.0%, 12.2%, 13.4%, and 40.3%, respectively. Participants reported a mean of 11.3 (SD=9.90) days of alcohol use in the past month, nearly half (48.0%) perceived to have a major problem with alcohol, and 61.4% met the threshold for harmful drinking. Multinomial logistic regression demonstrated that compared to the reference group (no AUD), all three AUD severity levels were associated with drinking frequency, problematic, and harmful alcohol use. However, only severe AUD was associated with personality disorders: (AOR=1.91, 95% CI=1.28, 2.86), MDD (AOR= 2.44, 95% CI= 1.62, 3.66) or PTSD (AOR= 1.65, 95% CI= 1.00, 2.71),. Similarly, only severe AUD was associated with impaired physical (AOR= 1.63, 95% CI= 1.01, 2.61), mental (AOR= 1.80, 95% CI= 1.16, 2.79), and social functioning (AOR= 1.87, 95% CI= 1.39, 2.51). This study adds to existing literature on clinical correlates of AUD by further elucidating the risk factors of the different AUD severity groups, while also highlighting an important, differential observation wherein measures of psychiatric disorders and functional impairment were only associated with severe AUD. The study suggests that the DSM-5 category of severe AUD most closely corresponds to AUD cases often found in secondary or tertiary treatment settings, and that cases of mild or moderate AUD may warrant less intensive treatment approaches. Future investigations should seek to examine the validity of the DSM-5 AUD three-level severity distinction by using longitudinal designs to evaluate change in mental health and functioning over time, along with their association with AUD severity classification.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Funding supported by grant R01DA018652

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

New York State Psychiatric Institute, Research Foundation for Mental Hygiene

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data for this study was collected as a part of a larger study investigating DSM-5 Substance Use Disorders (R01DA018652). For questions regarding data, please contact dsh2{at}cumc.columbia.edu

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 27, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Risk Factors for Mild, Moderate, and Severe Alcohol Use Disorder (AUD) in a sample of adult substance users: Implications for DSM-5 AUD Classification
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Risk Factors for Mild, Moderate, and Severe Alcohol Use Disorder (AUD) in a sample of adult substance users: Implications for DSM-5 AUD Classification
Zachary L. Mannes, Dvora Shmulewitz, Ofir Livne, Malka Stohl, Deborah Hasin
medRxiv 2020.10.26.20219824; doi: https://doi.org/10.1101/2020.10.26.20219824
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Risk Factors for Mild, Moderate, and Severe Alcohol Use Disorder (AUD) in a sample of adult substance users: Implications for DSM-5 AUD Classification
Zachary L. Mannes, Dvora Shmulewitz, Ofir Livne, Malka Stohl, Deborah Hasin
medRxiv 2020.10.26.20219824; doi: https://doi.org/10.1101/2020.10.26.20219824

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (141)
  • Anesthesia (44)
  • Cardiovascular Medicine (408)
  • Dentistry and Oral Medicine (67)
  • Dermatology (47)
  • Emergency Medicine (141)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4805)
  • Forensic Medicine (3)
  • Gastroenterology (177)
  • Genetic and Genomic Medicine (670)
  • Geriatric Medicine (70)
  • Health Economics (187)
  • Health Informatics (621)
  • Health Policy (314)
  • Health Systems and Quality Improvement (200)
  • Hematology (84)
  • HIV/AIDS (155)
  • Infectious Diseases (except HIV/AIDS) (5278)
  • Intensive Care and Critical Care Medicine (323)
  • Medical Education (91)
  • Medical Ethics (24)
  • Nephrology (73)
  • Neurology (677)
  • Nursing (41)
  • Nutrition (110)
  • Obstetrics and Gynecology (124)
  • Occupational and Environmental Health (203)
  • Oncology (437)
  • Ophthalmology (138)
  • Orthopedics (36)
  • Otolaryngology (88)
  • Pain Medicine (35)
  • Palliative Medicine (15)
  • Pathology (127)
  • Pediatrics (193)
  • Pharmacology and Therapeutics (129)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (765)
  • Public and Global Health (1796)
  • Radiology and Imaging (321)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (68)
  • Sports Medicine (61)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (28)
  • Urology (37)